Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bara

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Haemostasis|January 1, 1986
Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulationS Massonnet-Castel, E Pelissier, L Bara, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance studyL Hermans, M Bogaert, J P Degaute, et al.
Thrombosis Research. Supplement|January 1, 1991
Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.
British Journal of Haematology|February 1, 1991
Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteersM D Laforest, N Colas-Linhart, F Guiraud-Vitaux, et al.
Nature|October 15, 1992
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionF Cambien, O Poirier, L Lecerf, et al.
Transplantation|January 22, 2015
Gastrointestinal Endoscopy Is Safe in Patients Before and After Lung or Heart TransplantationHenrike Lenzen, Natascha Cieplik, Ahmed R Elkharsawi, et al.
The International Journal of Artificial Organs|December 1, 1994
An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesisG Babatasi, L Bara, F Galateau, et al.
Circulation|February 1, 1996
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du MyocardeI Behague, O Poirier, V Nicaud, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM StudyP Y Scarabin, L Bara, S Ricard, et al.
Atherosclerosis|January 5, 1996
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM studyA Lane, F Green, P Y Scarabin, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Haemostasis|January 1, 1986
Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulationS Massonnet-Castel, E Pelissier, L Bara, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance studyL Hermans, M Bogaert, J P Degaute, et al.
Thrombosis Research. Supplement|January 1, 1991
Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.
British Journal of Haematology|February 1, 1991
Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteersM D Laforest, N Colas-Linhart, F Guiraud-Vitaux, et al.
Nature|October 15, 1992
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionF Cambien, O Poirier, L Lecerf, et al.
Transplantation|January 22, 2015
Gastrointestinal Endoscopy Is Safe in Patients Before and After Lung or Heart TransplantationHenrike Lenzen, Natascha Cieplik, Ahmed R Elkharsawi, et al.
The International Journal of Artificial Organs|December 1, 1994
An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesisG Babatasi, L Bara, F Galateau, et al.
Circulation|February 1, 1996
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du MyocardeI Behague, O Poirier, V Nicaud, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM StudyP Y Scarabin, L Bara, S Ricard, et al.
Atherosclerosis|January 5, 1996
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM studyA Lane, F Green, P Y Scarabin, et al.
Pageof 9